-+ 0.00%
-+ 0.00%
-+ 0.00%

EUDA Health Subsidiary Signs Loan Convertible Agreement With Shenzhen Inno Immune To Invest Up To RMB6M In Two Tranches

Benzinga·01/13/2026 12:56:49
Listen to the news

EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that its wholly owned subsidiary, EUDA Health Pte. Ltd. ("EUDA Health"), has entered into a convertible loan agreement with Shenzhen Inno Immune Co., Ltd. ("Shenzhen Inno"), a developer of autologous cellular therapeutics and customised medicines for a wide range of diseases in China.

Under the terms of the agreement, EUDA expects to invest up to RMB 6 million in two tranches, consisting of an initial tranche of RMB 1 million and a second tranche of RMB 5 million, subject to the completion of due diligence, regulatory approvals, and execution of definitive agreements.